Neef, et al., Tetrahedron Letters, 32(38), 1991, pp. 5073-5076. |
Kubodera, et al., Chem Pharm Bull, 39(12), 1991, pp. 3221-3224. |
WO, A, 8910353 Deluca et al, Nov. 1989, See claim 1. |
Proc. Workshop on Vitamin D, 1988, N. Ikekawa: "Chemical synthesis of vitamin D analogs with selective biological activities", pp. 25-33, see p. 30, compound 20. |
Bioorganic Chemistry, vol. 17, No. 3, 1989, Eguchi et al, "Synthesis and biological activities of 22-hydroxy and 22-methoxy derivatives of 1, 25-dihydroxyvitamin D3: Importance of side chain conformation for biological activities", pp. 294-307 see the whole document. |
Chemical Abstracts, vol. 114, No. 17, 1991, see p. 820, abstract No. 164627h & JP, A. 02215766, Aug. 1990. |
Norman et al., Bioochem. Biophys. Res. Commun., 189, (1992), 1450-1456. |
Lowe et al., Vitamin D-Mediated Gene Expression, Critical Reviews in Eukaryotic Gene Expression, 2, (1992) 65-109. |
Calverley et al., Vitamin D in Antimumor Steroids, ed. by R. T. Blickenstaff, Academic Press, San Diego, (1992) 193-270. |
DeLuca, Ann. N Y Acad. Sci., 669, (1992) 59-69. |
M. Bower et al., Topical Calcipotriol Treatment In Advanced Breast Cancer, Lancet, 337, (1991 701-702. |
Oikawa et al., Anti-Cancer Drugs, 2, (1991) 475-480. |
K. W. Colston et al., Biochem. Pharmacol., 44, (1992) 693-702. |
A. Szabo et al., Kidney Int., 35, (1989) 1049-1056. |
A. J. Brown et al., J. Clin. Invest., 84, (1989) 728-732. |
Binderup, Biochem. Pharmacol., 43, (1992) 1885-1892. |
Binderup, Biochem. Pharmacol., 37, (1988) 889-895. |
Binderup et al., Biochem. Pharmacol., 42, (1991) 1569-1575. |